United States News All stories

McCormick (NYSE:MKC) reported second quarter 2026 net sales growth of 16.7%, driven by 1.7% organic growth and a 2.7% positive currency impact.

ProQR Therapeutics (NASDAQ:PRQR) reported positive Phase 1 target engagement data for AX-0810, its first Axiomer RNA editing candidate, in healthy volunteers.

Merck KGaA, Darmstadt, Germany has agreed to acquire Bio-Techne (NASDAQ:TECH) for $73 per share in cash, implying an enterprise value of $11.3 billion.

Acuity (NYSE:AYI) reported fiscal 2026 third-quarter net sales of $1.2 billion, up about 2% from a year earlier, as operating profit rose 38% to $193.3 million.

DeepHealth, a subsidiary of RadNet (NASDAQ:RDNT), received two FDA 510(k) clearances for its AI-powered Breast Suite, branded as Mammo Dx

Petrobras (NYSE:PBR) said its flagship Búzios field reached a record average production of 1.1 million barrels of oil per day, surpassing the previous record of 1 million barrels per day achieved in October 2025.

• Grayscale linked Bitcoin’s long-term outlook to Federal Reserve interest-rate policy, arguing that lower rates could support demand for digital store-of-value assets. 
• The theme connects several major crypto assets through monetary policy, institutional investment flows and growing adoption of exchange-traded products. 
• Persistent inflation, regulatory uncertainty and the risk of higher-for-longer interest rates remain key challenges for the sector. 

Amazon (NASDAQ:AMZN) said it will invest an additional $13 billion in India by 2030 to expand and support AI and cloud infrastructure.

Wendy’s exploded up to 42% intraday on June 24, halting for volatility after a viral WallStreetBets post called on traders to “save Wendy’s before it’s too late.”

H.B. Fuller (NYSE:FUL) made a recommended cash offer to acquire Advanced Medical Solutions for £715 million, expanding its medical adhesives portfolio.

Ionis Pharmaceuticals (NASDAQ:IONS) entered a license agreement giving Recordati (BIT) exclusive rights to develop and commercialize zilganersen outside the U.S., with Ionis receiving $30 million upfront.

Micron Technology (NASDAQ:MU) reported record third quarter fiscal 2026 revenue of $41.46 billion, significantly higher than $23.86 billion in the prior quarter and $9.30 billion a year ago.

Methode Electronics (NYSE:MEI) reported fourth-quarter fiscal 2026 net sales of $298.1 million, representing a 15.9% increase compared with the same period last year.

Worthington Steel (NYSE:WS) said its board of directors has declared a quarterly dividend of $0.16 per common share.

Pfizer (NYSE:PFE) has been dismissed from a large U.S. antitrust lawsuit in which multiple states accused drugmakers of fixing prices for generic medications.

Chemours Company (NYSE:CC) announced a settlement with the U.S. Environmental Protection Agency and West Virginia regulators to resolve claims related to PFAS discharges at three operating sites.

OpenAI has unveiled its first custom-designed AI chip, called Jalapeño, developed in partnership with Broadcom (NASDAQ:AVGO).

Alibaba Group Holding (NYSE:BABA) has filed a federal lawsuit in San Jose, California, against the U.S. Department of Defense, challenging its designation on a list of companies alleged to have ties to China’s military.

CMC (NYSE:CMC) declared a regular quarterly cash dividend of $0.20 per share on its common stock.

This payment represents the company’s 247th consecutive quarterly dividend.

ALZpath has entered a global licensing agreement with Abbott (NYSE:ABT) to support the development of an in vitro diagnostic blood test for Alzheimer’s disease using its proprietary pTau217 antibody.

LENZ Therapeutics (NASDAQ:LENZ) and Arrotex Pharmaceuticals have signed an exclusive license and commercialization agreement for VIZZ in Australia and New Zealand.

Oil prices declined on Wednesday, with Brent crude falling 1% to $76.30 per barrel and West Texas Intermediate dropping 1.1% to $72.43, extending losses to multi-month lows.

Eli Lilly (NYSE:LLY) has completed its acquisition of Centessa Pharmaceuticals, a clinical-stage company focused on orexin receptor 2 agonists for narcolepsy and other sleep-wake disorders.

Hudbay Minerals (NYSE:HBM) has completed its all-share acquisition of Arizona Sonoran Copper Company, with Arizona Sonoran now operating as a wholly owned subsidiary of Hudbay.